# Bio-Techne (TECH) — News TECH · NASDAQ · Stock Canonical page: https://www.lighthorse.io/tickers/tech/news ## Recent headlines - [Avtech Q3 EBITDA SEK 4.3 million](https://www.ainvest.com/news/avtech-q3-ebitda-sek-4-3-million-2610) — AInvest Wire, Oct 12, 2026 Avtech reported an Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of SEK 4.3 million for the third quarter of 2026. This metric reflects the company’s operating performance by excluding the impact of financing costs, tax policies, and non-cash accounting charges such as… - [Cleo Diagnostics Ltd - Cleo commences analytical validation ahead of FDA submission](https://www.ainvest.com/news/cleo-diagnostics-cleo-commences-analytical-validation-fda-submission-2610) — AInvest Wire, Oct 12, 2026 Cleo Diagnostics Limited (ASX: COV) has entered the analytical validation (AV) phase for its ovarian cancer detection blood test, marking a significant step toward its planned U.S. Food and Drug Administration (FDA) submission. This follows the completion of commercial assay development and key… - [Cleo Diagnostics - Receives first batch of commercially manufactured test kits](https://www.ainvest.com/news/cleo-diagnostics-receives-batch-commercially-manufactured-test-kits-2609) — AInvest Wire, Sep 2, 2026 Cleo Diagnostics Limited (ASX: COV) has received its first batch of commercially manufactured test kits from Bio-Techne, marking a key step in its regulatory pathway toward FDA submission. This development follows the commencement of kit manufacturing in April 2026 and supports the company’s… - [German Federal Cartel Office approves the takeover of Bio-Techne by Merck KGaA (Darmstadt)](https://www.ainvest.com/news/german-federal-cartel-office-approves-takeover-bio-techne-merck-kgaa-darmstadt-2608) — AInvest Wire, Aug 17, 2026 The German Federal Cartel Office has approved Merck KGaA’s (Darmstadt) proposed acquisition of Bio-Techne Corporation, a U.S.-based global provider of life science tools and analytical technologies. The approval marks a key regulatory milestone for the transaction, which is valued at approximately… - [Bio-Techne 4Q net sales $321.2M, est. $314.6M](https://www.ainvest.com/news/bio-techne-4q-net-sales-321-2m-est-314-6m-2608) — AInvest Wire, Aug 12, 2026 ## Similar Stocks - [TMO](https://www.lighthorse.io/tickers/tmo) — Thermo Fisher Scientific Inc Common Stock - [A](https://www.lighthorse.io/tickers/a) — Agilent Technologies, Inc. Common Stock - [RVTY](https://www.lighthorse.io/tickers/rvty) — Revvity, Inc. Common Stock - [MTD](https://www.lighthorse.io/tickers/mtd) — Mettler-Toledo International, Inc. Common Stock - [IQV](https://www.lighthorse.io/tickers/iqv) — IQVIA Holdings, Inc. Common Stock - [WAT](https://www.lighthorse.io/tickers/wat) — Waters Corporation Common Stock - [CRL](https://www.lighthorse.io/tickers/crl) — Charles River Laboratories International, Inc. Common Stock - [BIO](https://www.lighthorse.io/tickers/bio) — Bio-Rad Laboratories, Inc. Class A Common Stock - [DHR](https://www.lighthorse.io/tickers/dhr) — Danaher Corporation Common Stock --- Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express. This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness. Data provided by [AInvest](https://www.ainvest.com).